News on U.S. government agencies, U.S. politics, companies doing business with U.S. federal government. Read U.S. national and local news. This site is not affiliated with United States Government.
(EMAILWIRE.COM, April 19, 2012 ) Tampa, Florida – Morgan and Morgan is pleased to announce that attorney Michael Goetz has been appointed to the Plaintiffs’ Steering Committee (PSC) for the transvaginal mesh multidistrict litigation (MDL) actions against Ethicon, C.R. Bard, American Medical Systems and Boston Scientific. Pursuant to a recent federal court order, a singular PSC has been created to coordinate across MDL lines in the four separate vaginal mesh MDL actions pending in in the U.S. District Court for the Southern District of West Virginia before the Honorable Judge Joseph Goodwin. Mr. Goetz is honored to have been named to the PSC, a small group of attorneys chosen to guide the entire plaintiff’s side of the litigation.
“Being an effective member of this PSC will require a great deal of time and commitment,” said Mr. Goetz. “After speaking with dozens of our clients suffering from the effects of these products, I knew I wanted a leadership role to obtain a fair remedy for the harm they sustained."
The appointments to the PSC and other leadership roles in the ongoing vaginal mesh MDLs were announced on April 13 after Judge Goodwin approved a proposed counsel structure for the plaintiffs’ attorneys. By doing so, Judge Goodwin allowed for a coordinated and unified leadership spanning the four MDL actions comprised of the following: In re C.R. Bard, Inc. Pelvic Repair Systems Products Liability Litigation (MDL No. 2187);In re American Medical Systems, Inc. Pelvic Repair Systems Products Liability Litigation (MDL No. 2325); In re Boston Scientific Corp. Pelvic Repair Systems Products Liability Litigation(MDL No. 2326); and In re Ethicon, Inc. Pelvic Repair Systems Products Liability Litigation (MDL No. 2327). The plaintiffs in the lawsuits are women who were implanted with one or more of the manufacturers’ vaginal mesh products in the treatment of stress urinary incontinence (SUI) or pelvic organ prolapse (POP) and claim to have suffered serious physical and mental injuries as a result.
The FDA first brought to light reports of vaginal mesh complications in 2008 when it issued a public health notification on serious complications associated with transvaginal mesh placement. After issuing this statement, the agency reported that it saw the number of adverse events associated with vaginal mesh products continue to climb and issued an update in July 2011 informing the public that transvaginal mesh complications in the repair of POP are not rare. Surgical placement of the mesh through the vagina in the treatment of POP may expose patients to a greater risk than other surgical options without evidence of any greater clinical benefit, according to the FDA. Mesh erosion, severe pain, infection, urinary problems and recurrence of prolapse are among the side effects reportedly linked to the mesh products.
Mr. Goetz and his teams of medical device attorneys at Morgan and Morgan are currently handling and accepting new claims from women who suffered side effects following vaginal mesh surgery. For more information and a free case review, please visit http://www.forthepeople.com/vaginal-mesh-lawsuits--11-3179.html today.
About Morgan & Morgan
Morgan & Morgan is one of the largest plaintiff’s law firms in the country with multiple office locations throughout Florida and the Southeast. The firm handles auto accident cases, personal injury cases, and medical malpractice cases, as well as claims against drug and medical device manufacturers. Visit Morgan and Morgan online at http://www.forthepeople.com/ for a free case evaluation and information about your legal rights.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Industry resource center today to browse our selection of 600+ complimentary Industry magazines, white papers, webinars, podcasts, and more. Get popular titles including:
